After two weeks, hemorrhagic and gastrointestinal symptoms resolved without drug interruption, and she was re-evaluated with bone marrow aspiration (BMA) showing blast cells (BC) equal to 2% at morphology with persistence of the FLT3-ITD AR:0.3 at molecular biology. This evidence concerns the gene FLT3 and breast cancer.